Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Not yet recruiting
- Conditions
- Recurrent Prostate Cancer
- Registration Number
- NCT06070272
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition.
These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Male
- Target Recruitment
- 500
Inclusion Criteria
- Patient is at least 18 years of age
- Diagnosis of recurrent prostate cancer
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with study requirements
- Inability to provide written informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to participate in a recurrent prostate cancer clinical research 3 months Rate of patients who remain in recurrent prostate cancer clinical research to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States